cyclosporine has been researched along with African Lymphoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, F; Schmitt, KRL; Schubert, S; Tong, G; Wowro, SJ | 1 |
| Deschênes, G; Landman-Parker, J; Lucidarme, N; Nathanson, S | 1 |
| Bellier, C; Godeau, B; Khellaf, M; Lambotte, O | 1 |
| Andreeff, M; Bernstein, SH; Brookes, PS; Hilchey, S; Konopleva, M; Morse, K; Phipps, R; Ray, D; Salim, S; Tompkins, A; Young, SM | 1 |
| Burke, M; Crawford, DH; Hunt, BJ; Thomas, JA; Walker, H; Yacoub, M | 1 |
| Behm, FG; Campana, D; Ito, C; Pui, CH; Raimondi, SC; Ribeiro, RC | 1 |
| Gorin, NC; Landman, J; Laporte, JP; Lesage, S; Najman, A; Portnoï, MF; Rubinstein, P | 1 |
| Beluffi, G; Caselli, D; Maccabruni, A; Minoli, L | 1 |
| Díaz, MA; González Vicent, M; Madero, L | 1 |
| Grubb, DR; Johnson, KL; Lawen, A; Ly, JD; Vaillant, F | 1 |
| Díaz, MA; Madero, L; Merino, JM; Pareja, J | 1 |
| Dijkmans, BA; Jiwa, NM; Kluin, PM; Kluin-Nelemans, JC; van Rijthoven, AW; Zijlmans, JM | 1 |
1 trial(s) available for cyclosporine and African Lymphoma
| Article | Year |
|---|---|
Unrelated mismatched cord blood transplantation in patients with hematological malignancies: a single institution experience.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Burkitt Lymphoma; Cyclosporine; Erythropoietin; Female; Fetal Blood; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male | 1998 |
11 other study(ies) available for cyclosporine and African Lymphoma
| Article | Year |
|---|---|
Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Calcineurin; Cell Proliferation; Cell Survival; Cyclosporine; Drug Therapy, Combination; Epstein-Barr Virus Infections; Everolimus; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Mitochondria; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Tacrolimus; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2016 |
Long-term survival of renal graft complicated with Burkitt lymphoma.
Topics: Antimetabolites, Antineoplastic; Burkitt Lymphoma; Creatinine; Cyclosporine; Cytarabine; Graft Survival; Humans; Immunosuppressive Agents; Infant; Kidney Neoplasms; Kidney Transplantation; Liver Neoplasms; Male; Nephrotic Syndrome; Splenic Neoplasms | 2002 |
[Burkitt's lymphoma in a patient with systemic lupus erythematosus treated with immunosuppressive drugs. A case report].
Topics: Adult; Biopsy; Bone Marrow; Burkitt Lymphoma; Cyclophosphamide; Cyclosporine; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic | 2006 |
The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore.
Topics: Acetylcysteine; Animals; Apoptosis; B-Lymphocytes; Burkitt Lymphoma; Cyclosporine; Humans; Lymphoma, B-Cell; Male; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oleanolic Acid; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2007 |
Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Heart Transplantation; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Postoperative Complications; Prednisolone; Remission Induction; T-Lymphocytes, Cytotoxic; Tumor Virus Infections; Vincristine | 1996 |
Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells.
Topics: Adolescent; Apoptosis; Burkitt Lymphoma; Child; Child, Preschool; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Hematopoietic Stem Cells; Humans; Infant; Leukemia-Lymphoma, Adult T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Tumor Cells, Cultured | 1998 |
Cyclosporine for rectoperineal fistula in a human immunodeficiency virus-infected child.
Topics: Adolescent; Antiviral Agents; Burkitt Lymphoma; Child; Cyclosporine; Fistula; HIV Infections; Humans; Male; Perineum; Rectal Fistula | 1999 |
"Pseudotumor cerebri" following allogeneic bone marrow transplantation (BMT).
Topics: Bone Marrow Transplantation; Burkitt Lymphoma; Child; Cyclosporine; Female; Fever; Humans; Immunosuppressive Agents; Magnetic Resonance Spectroscopy; Pseudotumor Cerebri; Sinusitis; Tomography, X-Ray Computed; Transplantation, Homologous | 2001 |
Mitochondrial cytochrome c release is caspase-dependent and does not involve mitochondrial permeability transition in didemnin B-induced apoptosis.
Topics: Apoptosis; Bongkrekic Acid; Burkitt Lymphoma; Calcium Signaling; Caspase 9; Caspases; Cyclosporine; Cytochrome c Group; Depsipeptides; DNA Fragmentation; Enzyme Activation; HL-60 Cells; Humans; Intracellular Membranes; Ion Channels; Melanoma; Membrane Potentials; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Peptides, Cyclic; Permeability; Thapsigargin; Tumor Cells, Cultured | 2001 |
[Cyclosporin-related coma in bone marrow transplantation].
Topics: Adolescent; Bone Marrow Transplantation; Burkitt Lymphoma; Coma; Combined Modality Therapy; Cyclosporine; Humans; Male | 1992 |
Epstein-Barr virus-associated lymphoma in a patient with rheumatoid arthritis treated with cyclosporine.
Topics: Arthritis, Rheumatoid; Burkitt Lymphoma; Cyclosporine; Humans; Male; Middle Aged | 1992 |